Europe In-Vitro Toxicology Testing Market Report

European In-Vitro Toxicology Testing Market Size

The In-vitro toxicology testing market in Europe is projected to grow from USD 8416.77 million in 2024 to USD 22296.43 million by 2033, at a CAGR of 12.95%.

In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is essential in drug discovery as it identifies the poisonous effects of a new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time.

Increasing chronic diseases, growing aging population, rising technological advancements, growing demand for a healthy lifestyle, availability of government-supported anti-animal testing laws, and the existence of favorable regulatory policies (such as European government banned the production & sale of all animal-tested cosmetics in Europe) are driving the growth of in-vitro toxicology testing market in Europe. However, the high cost of technologies and lack of awareness on the in-vitro toxicology testing utilization are restraining the growth of the in-vitro toxicology testing market in Europe.

REGIONAL ANALYSIS

Based on product type, the Assays segment is estimated to command the largest share of the Europe in-vitro toxicology testing market by product in 2023. Systemic toxicity is assessed to control Europe's largest share in-vitro toxicology testing market by toxicity endpoints & tests in 2019. Technology is further segmented as OMICS technologies & cell culture technology.

Based on the Method, the In-silico method is estimated to command the largest share of the Europe in-vitro toxicology testing market by the method in 2023. The cosmetics & household products industry is expected to account for the largest market share of the Europe in-vitro toxicology testing market by industry in 2023.

Based on the region, Germany is estimated to account for the largest share of the Europe in-vitro toxicology testing market in 2023. In contrast, France is expected to grow at the highest CAGR during the forecast period.

KEY MARKET PLAYERS

Companies dominating European In-Vitro Toxicology Market profiled in this report are Covance, Inc. (A subsidiary of LabCorp) (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), General Electric Company (U.S.), BioReliance, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.) and Cyprotex (U.K.).

MARKET SEGMENTATION

This research report on the European In-Vitro Toxicology Testing Market has been segmented and sub-segmented into the following categories.

By Product

• Assays
• Reagents & Labware
• Services

By Type

• ADME
• Dose
• Toxic Substance

By Toxicity Endpoints & Tests

• Carcinogenicity
• Dermal Toxicity
• Genotoxicity

By Technology

• OMICS Technologies
• Cell Culture Technology

By Method

• Cellular Assays
• In-Silico Method

By Industry

• Cosmetics & Household Products
• Pharmaceutical

By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe